Long-term treatment of hypertension with chlorothiazide alone produces mioderate reduction in blood pressure in 66 per cent of patients with hypertension. This fall in pressure is due to a reduction in total peripheral resistance rather than a fall in cardiac output.
T HE value of any drug in the treatment of hypertension rests in the last analysis on the frequeney and magnitude of its depressor effect on the blood pressure and upon whether it corrects the elevated peripheral resistance, characteristic of essential hypertension. Although the hypotensive action of chlorothiazide has been previously studied, -3 nio attempt has yet been made to determine its usefulness in a large number of unselected hypertensive patients.
This report investigates the over-all effectiveness of long-term therapy with chlorothiazide in hypertension and studies the hemodynamic mechanism by which this treatment reduces the blood pressure.
Methods Clinical Observations
After preliminary cardiac and renal investigation, 83 unselected ambulatory patients with hypertension were given chlorothiazide as the sole hypotensive medication. None of these patients was edematous but 16 previously had had a splanchnicectomy that had not been successful in reducing the blood pressure. The usual maintenance dose of chlorothiazide was 0.5 Gm. twice daily after an initial 3-day period of 1 Gm. twice daily. In 5 patients a larger dose of 2 Gnm. per day was administered continuously. Patients were urged to reduce sodium intake by avoiding salty foods and by eliminating salt from cooking and at the table. In 14 patients blood pressure readings were taken twice daily at home and in the remainder readings were taken in the clinic. Treatment was mainFrom the Hypertension Unit, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Mich.
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tained for at least 1 miionth in all subjects, with the exception of 7 patients who had not responded after 2 weeks and whose clinical condition required the use of more potent drugs. At varying periods after the first month of treatment the remaining patients who failed to respond were withdrawn from the investigation to be given other drugs. The average duration of therapy for the entire group was 5.4 miionths.
Hemodynamic Observations
Henmodynamic studies were undertaken on 23 hypertensive out-patients in whom there was no clinical evidence of cardiac or renal failure and none had mnalignant hypertension. Plasma volume was measured in 10 patients and cardiac output in 16. Control observations were usually performed before starting treatment, but in 1 of the plasmavolume group and 4 of the cardiac-output group, chlorothiazide was administered first and was thereafter withdrawn or replaced by a placebo for a period of 1 month before the control observations were made. All these patients received the same dose of chlorothiazide, 1 Gm. per day, for at least 1 month before its effect was determined.
In order to study the early effects of the drug, these investigations were also performed on 7 patients before and within the 3 weeks of starting treatment. Cardiac output was measured in 4 subjects and plasma volume in 4 also.
Plasma volume was estimated by the dye-dilution inethod with Evans blue. 4 The total dose, whieh varied fromn 15 to 25 mg., was nmeasured by weighing the syringe before and after each injection. After the subject had been lying down for half an hour and a control sample of blood had been drawn, the dye was injected into the antecubital vein. The needle was flushed with 5 ml. of saline before and after the injection. After 15 minutes had elapsed to allow for intravascular mixing, 4 samples of blood were drawn, without venous congestion, at 5-minute intervals from an indwelling needle in the antecubital vein of the opposite arm. Hematocrit determinations were made on the second and fourth samples of blood. The concentration of Evans blue in the plasma was measured Circulation, Volume XXI, January 1960 At this tinme, the cardiac index remained depressed, but the blood pressure had fallen further and peripheral resistanee had returned to the pretreatment level.
Siniee these findings were at varianee with those previously reported2' 10 11 in hospitalized patienits given chlorothiazide for shorter periods, plasma volume and cardiac output determinations were made before and after chlorothiazide had been administered for 5 to 19 days in 7 patients (table 4). In contrast to our previous findings, these patients exhibited a considerable fall in plasma volume (average 399 nml.) and in cardiac index (average 1.0 L. per minute) (table 4).
Discussion Effect of Chlorothiazide on the Blood Pressure
The clinical usefulness of chlorothiazide has been somewhat overshadowed by the ability of this drug to enhan-ce the effectiveness of other hypotensive drugs.2 3 12 13 It is particularly satisfying to observe that two thirds of the patients with hypertension respond to chilorothiazide alone and that in 50 per cent of the milder cases, with diastolic pressures Figure 2 Effect of chlorothiazide therapy on mean blood pressure, cardiac index, and peripheral resistance in 16 patients. OFF = control observations without treatment; ON = after at least 28 days of treatment.
Mode of Action
During the initiation of chlorothiazide therapy, there is a fall in body weight and an associated loss of extracellular fluid volume2 and of plasma volume.' 10 As a result cardiac output falls.10' 11, 15 Our data confirm this and differ from those of Aleksandrow et al., 16 who found no change in cardiac output after 5 days of chlorothiazide therapy. Since restoration of plasma volume by the infusion of dextran will restore the blood pressure to its previous level,10 15 
